Insider · CIK 0001657768

TAKANASHI KEN

Reports to the SEC for 2 companies · KAGOSHIMA

sec.gov

Transactions

Companies

Filings

CIK

0001657768

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	WVEWave Life Sciences, Inc.A Award	Director	AAward	+10.7K sh	—	—	30,779
2026-10-05	WVEWave Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+64K sh	—	—	64,000
2026-08-11	WVEWave Life Sciences, Inc.S Sale	Director	SSale	−3,864 sh	$6.01	−$23.2K	20,079
2026-03-23	WVEWave Life Sciences, Inc.C Conversion	Director	CConversion	+3.9M sh	—	—	9,606,408
2026-03-23	WVEWave Life Sciences, Inc. · Series A Preferred SharesC Conversion	Director	CConversion	−3.9M sh	—	—	0
2025-08-11	WVEWave Life Sciences, Inc.A Award	Director	AAward	+12.7K sh	—	—	5,729,003
2025-08-11	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+76.2K sh	—	—	76,200
2025-08-05	WVEWave Life Sciences, Inc.S Sale	Director	SSale	−4,872 sh	$8.75	−$42.6K	5,716,303
2024-08-12	WVEWave Life Sciences, Inc.A Award	Director	AAward	+16.1K sh	—	—	5,721,175
2024-08-12	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+32.2K sh	—	—	32,230
2023-08-07	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−10K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−20K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−30K sh	—	—	0
2023-06-06	Satsuma Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+22.1M sh	$0.91	+$20.1M	24,847,694
2022-08-15	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2021-08-16	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2020-12-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2020-08-18	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2020-06-12	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+10K sh	—	—	10,000
2019-09-17	Satsuma Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+33.7K sh	—	—	1,021,276
2019-09-17	Satsuma Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+307K sh	—	—	1,328,386
2019-09-17	Satsuma Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+233K sh	$15.00	+$3.5M	1,561,719
2019-09-17	Satsuma Pharmaceuticals, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−33.7K sh	—	—	0
2019-09-17	Satsuma Pharmaceuticals, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−307K sh	—	—	0
2019-08-15	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2018-08-13	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2017-08-10	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2016-11-10	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-11-16	WVEWave Life Sciences, Inc.C Conversion	Director	CConversion	+162K sh	—	—	1,859,130
2015-11-16	WVEWave Life Sciences, Inc.P Purchase	Director	PPurchase	+125K sh	$16.00	+$2M	1,984,130
2015-11-16	WVEWave Life Sciences, Inc. · Series B Preferred SharesC Conversion	Director	CConversion	−162K sh	—	—	0
2015-08-14	WVEWave Life Sciences, Inc. · Series B Preferred SharesP Purchase	Director	PPurchase	+162K sh	$12.37	+$2M	161,663

Recent filings

Accepted (ET)
Oct 74
TAKANASHI KEN0001193125-26-417235
SEC(opens sec.gov)
Aug 134
TAKANASHI KEN0001193125-26-349961
SEC(opens sec.gov)
Mar 264
TAKANASHI KEN0001193125-26-126276
SEC(opens sec.gov)
Aug 134
TAKANASHI KEN0000950170-25-108289
SEC(opens sec.gov)
Aug 74
TAKANASHI KEN0000950170-25-105353
SEC(opens sec.gov)
Aug 144
TAKANASHI KEN0000950170-24-097283
SEC(opens sec.gov)
Aug 94
TAKANASHI KEN0000899243-23-017915
SEC(opens sec.gov)
Jun 84
TAKANASHI KEN0000899243-23-014896
SEC(opens sec.gov)
Dec 94/A
TAKANASHI KEN0001567619-22-021461
SEC(opens sec.gov)
Aug 174
TAKANASHI KEN0000899243-22-029096
SEC(opens sec.gov)
Jun 74
TAKANASHI KEN0001567619-22-012473
SEC(opens sec.gov)
Aug 184
TAKANASHI KEN0000899243-21-033527
SEC(opens sec.gov)
Dec 74
TAKANASHI KEN0001567619-20-020722
SEC(opens sec.gov)

Companies

Address

C/O SHIN NIPPON BIOMEDICAL LABORATORIES, 2438 MIYANOURA-MACHI, KAGOSHIMA CITY

KAGOSHIMA, 891-1394